SynthesisFrontiers in endocrinology2023
Cardiovascular outcomes and safety of SGLT2 inhibitors in chronic kidney disease patients.
Xiutian Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this paperpooled itcites it